Decoglurant

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Decoglurant
Decoglurant.svg
Systematic (IUPAC) name
5-[2-[7-(trifluoromethyl)-5-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]pyridin-2-amine
Clinical data
Legal status
?
Identifiers
CAS number 911115-16-7
ATC code None
PubChem CID 71533696
Chemical data
Formula C21H11F6N5 
Mol. mass 447.336 g/mol

Decoglurant (INN; RG1578) is a negative allosteric modulator of the mGlu2 and mGlu3 receptors which is under development by Roche for the treatment of major depressive disorder (as an adjunct).[1][2] As of August 2014, it is in phase II clinical trials.[1][2]

See also[edit]

References[edit]

  1. ^ a b "Roche - Pipeline". 2014. Retrieved 2014-08-01. 
  2. ^ a b "Roche Group Development Pipeline". 2014. Retrieved 2014-08-01.